Poseida Therapeutics (PSTX)

Poseida Therapeutics (PSTX) Stock Price & Analysis


PSTX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.95 - $8.82
Previous Close$2.38
Average Volume (3M)722.84K
Market Cap
Enterprise Value$47.21M
Total Cash (Recent Filing)$247.20M
Total Debt (Recent Filing)$87.89M
Price to Earnings (P/E)-3.9
Aug 10, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.61
Shares Outstanding86,775,546
10 Day Avg. Volume496,003
30 Day Avg. Volume722,835
Standard Deviation0.20
Financial Highlights & Ratios
Price to Book (P/B)1.46
Price to Sales (P/S)19.97
Price to Cash Flow (P/CF)-1.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.34
Enterprise Value/Gross Profit0.36
Enterprise Value/Ebitda-1.23
Price Target Upside502.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Poseida Therapeutics’s price range in the past 12 months?
Poseida Therapeutics lowest stock price was $1.95 and its highest was $8.82 in the past 12 months.
    What is Poseida Therapeutics’s market cap?
    Currently, no data Available
    When is Poseida Therapeutics’s upcoming earnings report date?
    Poseida Therapeutics’s upcoming earnings report date is Aug 10, 2023 which is in 74 days.
      How were Poseida Therapeutics’s earnings last quarter?
      Poseida Therapeutics released its earnings results on May 09, 2023. The company reported -$0.45 earnings per share for the quarter, beating the consensus estimate of -$0.451 by $0.001.
        Is Poseida Therapeutics overvalued?
        According to Wall Street analysts Poseida Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Poseida Therapeutics pay dividends?
          Poseida Therapeutics does not currently pay dividends.
          What is Poseida Therapeutics’s EPS estimate?
          Poseida Therapeutics’s EPS estimate is -$0.55.
            How many shares outstanding does Poseida Therapeutics have?
            Poseida Therapeutics has 86,775,540 shares outstanding.
              What happened to Poseida Therapeutics’s price movement after its last earnings report?
              Poseida Therapeutics reported an EPS of -$0.45 in its last earnings report, beating expectations of -$0.451. Following the earnings report the stock price went down -0.294%.
                Which hedge fund is a major shareholder of Poseida Therapeutics?
                Among the largest hedge funds holding Poseida Therapeutics’s share is Aisling Capital Management LP. It holds Poseida Therapeutics’s shares valued at 3M.


                  Poseida Therapeutics Stock Smart Score

                  The Poseida Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Poseida Therapeutics

                  Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumors.


                  Top 5 ETFs holding PSTX

                  Market Value
                  Smart Score
                  iShares Biotechnology ETF
                  iShares NASDAQ US Biotechnology UCITS ETF
                  Fidelity MSCI Health Care Index ETF
                  Invesco Nasdaq Biotechnology ETF
                  Up to five ETFs with an Outperform Smart Score that hold PSTX. The ETFs are listed according to market value of PSTX within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Atara Biotherapeutics
                  Scholar Rock Holding
                  C4 Therapeutics
                  Lexicon Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis